6 research outputs found
Pharmacological treatment of obesity in clinical practice
No full textAnti-obesity medications may be considered in the subjects with BMI ≥30 kg/m2, or with BMI 27-29.9 kg/m2 and weight-related comorbidities, whom weight reduction is not achieved via lifestyle modifications alone. If weight loss is inadequate ( [Med-Science 2021; 10(2.000): 651-7
Ischemia modified albumin levels and its association with clinical follow-up in acute renal failure
No full textMay ischemia modified albumin be a predictor in diagnosis of contrast induced nephropathy?
No full text
